Press Releases
 
Worldwide Analysis Of China Cancer Drugs Market By Cancer Types - Lung, Stomach, Breast, etc

India, 15 January 2019 -- Researchmoz added Most up-to-date research on "Worldwide Analysis Of China Cancer Drugs Market By Cancer Types - Lung, Stomach, Breast, etc" to its huge collection of research reports.

Anti-Cancer drugs are the drugs which are used to reduce or prevent the cell proliferation of cancerous tissues. China Cancer Drugs Market is projected to reach US$ 30 Billion by the year 2024; owing to the increasing prevalence of various types of cancer, changing lifestyle & dietary habits, growing aging population, rising demand of targeted drug therapy and the patent expiration of key cancer drugs. Cancer is one of the leading causes of death worldwide and is a major public health burden in both developed and developing countries.
The rate of cancer incidences in China is exploding very rapidly; nearly 4 million people diagnosed and almost 3 million died from it. For instance; due to increasing air pollution over the last couple of years, lung cancer has increased 50% in Beijing only. Anticancer drugs act like an inhibitor that prevents cancer cells to grow.
In addition; factors like growing awareness regarding cancer diagnosis & treatment, advancement in cancer drugs and therapies, rise in cancer awareness programs like breast cancer screening, investment in healthcare infrastructure are expected to drive China anti-cancer drugs market positively over the forecast period. However, major side-effects of cancer drugs and its high cost are certainly restraining the China anti-cancer drugs market to reach its full potential.
Renub Research report titled “China Cancer Drugs Market, by Drugs [Cytotoxic Drugs (Antimetabolities, Plant Alkaloids, Alkylating Agents), Targeted Drugs, Monoclonal Antibiotics, Hormonal Drugs, Traditional Chinese Medicine (TCM), & Others], Cancer (Lung, Stomach, Breast, Esophageal, Liver & Others), Therapy (Chemotherapy, Targeted Therapy, Hormonal Therapy & Others), Companies (Merck, Celgene, Eli Lilly, Roche & Sino BioPharma)” provides a complete analysis of China Anti-Cancer Drugs Market.

To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=1873926

By Drugs – Cytotoxic Drugs leads the Cancer Drugs Market in China
Based on the drugs type, China cancer drugs market is segmented into cytotoxic drugs, targeted drugs, Monoclonal Antibiotics, hormonal drugs, TCM and Others. The cytotoxic drugs segment is further classified into Antimetabolites, Plant Alkaloids and Alkylating Agents.
By Cancer – Lungs Cancer accounts for the largest share of China Cancer Drugs Market
On the basis of cancer type, China cancer drugs market is segmented into Lung, Stomach, Breast, Esophageal, Liver & Others. Lung, Breast and Stomach Cancer dominates the China anti-cancer drugs market and is expected to do so in the near future.
By Therapy – Targeted Therapy is expected to grow significantly during the forecast period
By therapy type, the China anti-cancer drugs market is segmented into chemotherapy, targeted therapy, hormonal therapy and others. Chemotherapy and targeted therapy together held the major share of China cancer drugs market.

Browse TOC @ https://www.researchmoz.us/china-cancer-drugs-market-by-drugs-cytotoxic-targeted-etc-cancer-typeslung-stomach-breast-etc-by-therapy-companies-report.html/toc

Company Analysis
Some of the prominent companies competing in the China Anti-Cancer Drugs Market, and profiled in the report include Merck, Celegene, Eli Lilly, Roche and Sino BioPharma.
This market research report provides a complete analysis of the China Cancer Drugs Market, Growth Drivers, Challenges, and their projections for the upcoming years.
By Drugs
Cytotoxic Drugs
Antimetabolities
Plant Alkaloids
Alkylating Agents
Targeted Drugs
Monoclonal Antibiotics
Hormonal Drugs
Traditional Chinese Medicine (TCM)
Others
By Cancer
Lung Cancer
Stomach Cancer
Breast Cancer
Esophageal Cancer
Liver Cancer
Others
By Therapy
Chemotherapy
Targeted Therapy
Hormonal Therapy
Others
Companies Covered in the Report
Merck
Celegene
Eli Lilly
Roche
Sino BioPharma

# # #


Submitted by prashantkolekar, researchmoz.us on Tuesday, 15 January 2019 at 12:01 AM
Category: Health Care & Medical
 
Related News

Huber Needle Market Trends and Growth Factors Analysis 2016-2026
Tuesday, 26 Mar 2019

Blood Component Extractor Market Current Trends and Future Aspect Analysis 2016-2024
Tuesday, 26 Mar 2019

Diuretic Agents Market Future Opportunities 2025
Monday, 25 Mar 2019

Betalactam Drugs Market Size, Status and Forecast to 2025
Monday, 25 Mar 2019

Antihyperlipidemic Drugs Market: Shares, Strategies and Forecasts, Analysis and Overview upto 2025
Monday, 25 Mar 2019

Related Events

Diagnostic Imaging Update on Kauai
Monday, 25 Mar 2019

Medical Device Safety and Reporting Summit
Monday, 25 Mar 2019

8th Drug Formulation and Bioavailability
Monday, 25 Mar 2019

Slow- and Controlled-Release and Stabilized Fertilizers (SCRSFs)
Monday, 25 Mar 2019

3rd Product Complaints Forum
Monday, 25 Mar 2019

Latest News

Huber Needle Market Trends and Growth Factors Analysis 2016-2026
Tuesday, 26 Mar 2019

Blood Component Extractor Market Current Trends and Future Aspect Analysis 2016-2024
Tuesday, 26 Mar 2019

Andre Porter Book to Film Tour
Tuesday, 26 Mar 2019

Safezone.Tips Stand The Best Place Online To Get Free SafeZone Pass To Start Exploring
Monday, 25 Mar 2019

New Silkroutes Group sells its energy unit for US$10 million
Monday, 25 Mar 2019

 
Want to get your press releases, event listings, and job ads on Scoopasia? Register now for a FREE account or login if you already have one!
Scoopasia v1.0b. Copyright © 2019
Today is Tuesday, 26 March 2019

About Scoopasia | FAQ | Privacy Policy | Contact Us

Press Releases
Event Listings
Job Listings
Arts & Entertainment
Architecture & Construction
Automotive & Travel
Business
Consumer Technology
Economy
Education
Enterprise Technology
Food & Fashion
Government & Policy
Health Care & Medical
Legal/Law
News & Media
Religion
Science & Research
Sports & Fitness
Login / Register
Get Scoopasia through RSS Feeds & Email Notifications!


Journalist's Toolbox
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

  • Scoop Line
    (Instant Information Request)
    The easiest way to ask questions and request information from the PR community.


  • Advanced Search
    Drill down, dig deep, for media information the way you want it.

  • Journalist's Resources
    Resources and tools you can't do without.

  • PR Tools
    Scoopasia Blog Search
    Search the largest handpicked collection of Asia's most prominent and influential blogs.


    Resources
  • PR Bookmarks
  • Web 2.0 Bookmarks
  • Media Bookmarks

    More Coming Soon...

  • Upcoming Events
  • Palo Alto Networks: CCISDA Spring Conference 2019
  • Diagnostic Imaging Update on Kauai
  • 2nd Pharmacovigilance Audit and Inspection Conference
  • Medical Device Safety and Reporting Summit
  • 8th Drug Formulation and Bioavailability

  • Latest Jobs
    Sorry, there are currently no entries posted here.